BioMarin Pharmaceutical Inc (BMRN) Operating income 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual operating income history from SEC filings — each fiscal year as reported.
$409.5MFY2025 · since FY2016: -$803.4M → $409.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $409.5M | -15.4% |
| FY2024 | $484.2M | +160.6% |
| FY2023 | $185.8M | +15.4% |
| FY2022 | $161.0M | +295.5% |
| FY2021 | -$82.3M | -89.6% |
| FY2020 | -$43.4M | +56.8% |
| FY2019 | -$100.5M | +18.7% |
| FY2018 | -$123.5M | -740.3% |
| FY2017 | -$14.7M | +98.2% |
| FY2016 | -$803.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice